Total Payments
$916,165
2024 Payments
$178,906
Companies
22
Transactions
840
Medicare Patients
976
Medicare Billing
$122,650
Payment Breakdown by Category
Other$703,305 (76.8%)
Travel$97,468 (10.6%)
Consulting$96,093 (10.5%)
Food & Beverage$19,097 (2.1%)
Education$161.80 (0.0%)
Gifts$40.59 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $641,159 | 211 | 70.0% |
| Travel and Lodging | $97,468 | 254 | 10.6% |
| Consulting Fee | $96,093 | 20 | 10.5% |
| Honoraria | $61,018 | 21 | 6.7% |
| Food and Beverage | $19,097 | 330 | 2.1% |
| Long term medical supply or device loan | $1,128 | 1 | 0.1% |
| Education | $161.80 | 2 | 0.0% |
| Gift | $40.59 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mallinckrodt Hospital Products Inc. | $206,015 | 164 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $197,633 | 209 | $0 (2019) |
| Gilead Sciences, Inc. | $148,810 | 99 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $106,418 | 103 | $0 (2024) |
| Merck Sharp & Dohme LLC | $90,125 | 106 | $0 (2024) |
| La Jolla Pharmaceutical Company | $54,545 | 34 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $48,883 | 41 | $0 (2023) |
| JAZZ PHARMACEUTICALS INC. | $20,625 | 7 | $0 (2019) |
| ANI Pharmaceuticals, Inc. | $12,620 | 29 | $0 (2024) |
| Advanced Respiratory, Inc | $11,011 | 17 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $178,906 | 167 | Mallinckrodt Hospital Products Inc. ($89,074) |
| 2023 | $205,730 | 175 | IDORSIA PHARMACEUTICALS US INC ($81,605) |
| 2022 | $107,537 | 96 | Gilead Sciences, Inc. ($34,567) |
| 2021 | $87,777 | 60 | Mallinckrodt Hospital Products Inc. ($33,716) |
| 2020 | $49,184 | 32 | Mallinckrodt Hospital Products Inc. ($29,062) |
| 2019 | $143,529 | 140 | Mallinckrodt Enterprises LLC ($91,169) |
| 2018 | $95,630 | 117 | Mallinckrodt LLC ($58,741) |
| 2017 | $47,872 | 53 | Mallinckrodt LLC ($47,723) |
All Payment Transactions
840 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Philips North America LLC | (8269) DreamStation Cpap (Device) | Long term medical supply or device loan | In-kind items and services | $1,128.08 | General |
| Category: Medical Device | ||||||
| 12/20/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/19/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Travel and Lodging | In-kind items and services | $417.33 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/19/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Travel and Lodging | In-kind items and services | $206.19 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/19/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $123.74 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/19/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Travel and Lodging | In-kind items and services | $80.00 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/19/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Travel and Lodging | In-kind items and services | $38.99 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/17/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Travel and Lodging | In-kind items and services | $748.48 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/17/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Travel and Lodging | In-kind items and services | $629.10 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/17/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Travel and Lodging | In-kind items and services | $398.99 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/17/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Travel and Lodging | In-kind items and services | $347.08 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/17/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $123.12 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/17/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Travel and Lodging | In-kind items and services | $80.00 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/17/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Travel and Lodging | In-kind items and services | $80.00 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/16/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,452.50 | General |
| Category: Insomnia | ||||||
| 12/11/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Consulting Fee | Cash or cash equivalent | $2,600.00 | General |
| Category: Airway Clearance Device | ||||||
| 12/11/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Insomnia | ||||||
| 12/10/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,500.00 | General |
| Category: COVID-19 | ||||||
| 12/04/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Honoraria | Cash or cash equivalent | $3,528.00 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 12/04/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $126.56 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 11/26/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: COVID-19 | ||||||
| 11/21/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $720.00 | General |
| Category: COVID-19 | ||||||
| 11/19/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Travel and Lodging | Cash or cash equivalent | $393.75 | General |
| Category: CRITICAL CARE | ||||||
| 11/19/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | Cash or cash equivalent | $16.98 | General |
| Category: CRITICAL CARE | ||||||
| 11/19/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | Cash or cash equivalent | $8.35 | General |
| Category: CRITICAL CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 247 | 334 | $109,105 | $25,276 |
| 2022 | 6 | 212 | 279 | $124,220 | $28,458 |
| 2021 | 6 | 224 | 345 | $121,285 | $29,526 |
| 2020 | 5 | 293 | 507 | $150,918 | $39,390 |
Total Patients
976
Total Services
1,465
Medicare Billing
$122,650
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 56 | 68 | $36,380 | $6,828 | 18.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 43 | 98 | $16,660 | $6,330 | 38.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 74 | 91 | $25,025 | $5,042 | 20.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 25 | $8,000 | $2,755 | 34.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 16 | 16 | $12,000 | $1,996 | 16.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 12 | 12 | $4,800 | $983.62 | 20.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 12 | 12 | $4,800 | $839.40 | 17.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 12 | $1,440 | $502.20 | 34.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 98 | 136 | $72,760 | $16,327 | 22.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 28 | 28 | $21,000 | $3,981 | 19.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 37 | 62 | $10,540 | $3,809 | 36.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 16 | 16 | $5,120 | $1,864 | 36.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 18 | 19 | $7,600 | $1,545 | 20.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 15 | 18 | $7,200 | $932.54 | 13.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 66 | 144 | $24,480 | $8,519 | 34.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 39 | 55 | $29,425 | $6,446 | 21.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 56 | 78 | $31,200 | $6,386 | 20.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 30 | 30 | $22,500 | $4,375 | 19.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 19 | 19 | $6,080 | $2,150 | 35.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 14 | 19 | $7,600 | $1,650 | 21.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 105 | 292 | $49,640 | $18,370 | 37.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 80 | 102 | $54,570 | $8,474 | 15.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 65 | 68 | $21,760 | $7,923 | 36.4% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 25 | 25 | $18,750 | $3,247 | 17.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 18 | 20 | $6,198 | $1,377 | 22.2% |
About Dr. Rajkumar Dasgupta, M.D
Dr. Rajkumar Dasgupta, M.D is a Pulmonary Disease healthcare provider based in Pasadena, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437117421.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rajkumar Dasgupta, M.D has received a total of $916,165 in payments from pharmaceutical and medical device companies, with $178,906 received in 2024. These payments were reported across 840 transactions from 22 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($641,159).
As a Medicare-enrolled provider, Dasgupta has provided services to 976 Medicare beneficiaries, totaling 1,465 services with total Medicare billing of $122,650. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Internal Medicine, Sleep Medicine
- Location Pasadena, CA
- Active Since 05/02/2006
- Last Updated 01/28/2026
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1437117421
Products in Payments
- ACTHAR (Biological) $358,556
- Veklury (Drug) $147,631
- QUVIVIQ (Drug) $106,418
- ZERBAXA (Drug) $67,474
- OFEV (Drug) $48,883
- GIAPREZA (Drug) $48,165
- TERLIVAZ (Drug) $45,092
- RECARBRIO (Drug) $14,697
- PURIFIED CORTROPHIN GEL (Drug) $12,620
- Xyrem (Drug) $12,375
- XYREM (Drug) $8,100
- The MetaNeb System (Device) $6,997
- XERAVA (Drug) $6,259
- Vabomere (Drug) $5,858
- Moderna Covid-19 Vaccine (Biological) $4,640
- Hillrom - Vest System Model 105 Home Care (Device) $2,634
- S&RC Und (Device) $2,367
- Hillrom - Life 2000 Ventilation System (Device) $2,280
- (8269) DreamStation Cpap (Device) $1,128
- The Vest System 205 Acute Care (Device) $700.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Pasadena
Dr. Donald Kroe, M.d, M.D
Pulmonary Disease — Payments: $9,010
Pulmonary Disease $9,010
Ashish Patel, Md, MD
Pulmonary Disease — Payments: $8,866
Pulmonary Disease $8,866
Dr. Michael Gurevitch, M.d, M.D
Pulmonary Disease — Payments: $8,728
Pulmonary Disease $8,728
Pang-Chieh Eu, M.d, M.D
Pulmonary Disease — Payments: $1,732
Pulmonary Disease $1,732
Magdalena Arenas, Md, MD
Pulmonary Disease — Payments: $1,199
Pulmonary Disease $1,199
Chitra Ramakrishnan, M.d, M.D
Pulmonary Disease — Payments: $834.80
Pulmonary Disease $834.80